Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis ☆

Overview of attention for article published in ESMO Open, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

So far, Altmetric has seen 56 X posts from 49 X users, with an upper bound of 158,370 followers.

RT @GuiNaderMarta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at @ESMO_Open ctDNA is a…

RT @OM3d_: 🔹Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis…

🔹Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis #BreastCancer @GuiNaderMarta @ElisaAgostinett @OncoAlert https://t.co/LZiaB6gJan https://t.co/TGktPLbRxo

RT @GuiNaderMarta: Our meta-analysis looking at the prognostic value of ctDNA in early breast cancer is now out at @ESMO_Open ctDNA is a…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 52 additional X posts.